Introduction
Under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), getting a device onto the market isn't the end of the clinical evidence conversation — it's closer to the middle. Manufacturers are expected to keep generating clinical evidence throughout the device's life on the market, through a structured activity called postmarket clinical follow-up, or PMCF. The person who owns that work day to day is usually called a PMCF specialist, though the title varies — some companies fold it into a clinical affairs or clinical evidence role, others keep it as its own position, especially at manufacturers with a large portfolio of CE-marked devices.
It's a role that sits at the intersection of clinical affairs, regulatory affairs, and quality, and it's become more structured and more visible since MDR and IVDR raised the bar on what "adequate" postmarket clinical evidence actually looks like. Before MDR, postmarket clinical data collection for many devices was comparatively light-touch, often limited to literature review and passive vigilance monitoring. MDR made PMCF an explicit, documented, and actively planned obligation for the large majority of device classes, which is a big part of why this has become a job in its own right rather than something handled as an afterthought by whoever had spare capacity. If you're curious what the job involves beyond the acronym, here's a practical look.
The Core Responsibility: Keeping the Clinical Evidence Current
A PMCF specialist's central job is making sure the clinical evaluation for a device doesn't go stale. Under MDR, the clinical evaluation report (CER) is a living document, not a one-time submission artifact, and PMCF is the mechanism for feeding it new data: confirming that the device performs as intended in real-world use, identifying previously unknown side effects or risks, and verifying that the benefit-risk profile established at CE marking still holds once the device is in wider use across more patients and settings than any pre-market study could cover.
In practice, this means the PMCF specialist owns the PMCF plan — a regulatory document required under MDR/IVDR Annex XIV that lays out what postmarket clinical activities will be conducted, why, on what timeline, and how results will feed back into the clinical evaluation and risk management file. Writing and maintaining that plan, then actually executing against it, is the backbone of the role.
What the Work Looks Like Week to Week
A few activities make up most of the job:
- Designing and running PMCF activities. This can range from a structured PMCF study or survey to systematic literature review, registry participation, or analysis of real-world data the company already collects. The specialist decides (often with clinical and regulatory leadership) which methods fit the device's risk class and the specific evidence gaps.
- Writing and updating the PMCF plan and PMCF evaluation report. These are living documents that get revisited on a schedule tied to the device's risk classification — more frequently for higher-risk devices.
- Feeding findings into the clinical evaluation report and risk management file. PMCF isn't a standalone exercise; new data has to flow back into the CER and into the risk management documentation maintained under ISO 14971, and a trend that looks concerning has to trigger the right internal escalation.
- Coordinating with vigilance and complaint-handling teams. PMCF data and postmarket surveillance (PMS) data overlap, and the specialist usually has to reconcile what's coming out of complaint trends, field safety actions, and formal PMCF studies into one coherent clinical picture.
- Working with notified bodies. PMCF plans and reports are reviewed by the notified body as part of ongoing CE marking surveillance, so the specialist often prepares documentation for notified body audits and responds to their questions directly.
How It Connects to Regulatory Affairs
PMCF sits close enough to regulatory affairs that at smaller manufacturers, a regulatory affairs specialist may own it outright rather than it being a separate clinical role. Even where it's a distinct position, PMCF specialists work constantly with regulatory affairs because PMCF outcomes can trigger regulatory actions — a labeling update, a risk management file revision, or in a serious case, a field safety corrective action. Understanding the regulatory consequences of what a PMCF study finds, not just the clinical methodology, is part of what makes someone effective in this role rather than purely a clinical researcher bolted onto a device company.
This is also a role where the EU regulatory framework drives most of the formal structure, even for companies based elsewhere. A US manufacturer selling CE-marked devices in Europe needs the same PMCF discipline as an EU-based company, which means the role often exists inside US and global medical device companies specifically to serve their European business.
What Makes Someone Good at This Job
The specialists who do this well tend to be comfortable moving between two different registers: the methodological rigor of designing a study or survey that will actually produce usable data, and the document-and-deadline discipline of keeping a regulatory file current against notified body expectations. A clinical research or epidemiology background is common, often paired with time spent in regulatory or quality roles at a device manufacturer. Familiarity with MDR/IVDR Annex XIV and MEDDEV or MDCG guidance on PMCF specifically (rather than general clinical trial knowledge) is usually expected, since the EU framework has its own vocabulary and its own expectations for what counts as adequate follow-up.
It also helps to be a clear writer. PMCF plans and evaluation reports are read closely by notified body reviewers, and a document that's vague about methodology or timelines tends to generate more questions — and more delay — than one that's specific from the start.
A Note on Risk Classification and Workload
How much of a specialist's time any single device takes up depends heavily on its risk class. A low-risk Class I device might need relatively lightweight PMCF activity — periodic literature review and confirmation that complaint trends remain consistent with the known safety profile. A Class III implantable device typically needs a much more active PMCF program, potentially including a dedicated postmarket study with defined enrollment targets, follow-up intervals, and statistical analysis plans. A specialist managing a varied device portfolio has to triage across these different obligations, keeping the highest-risk devices' PMCF activity current while not letting lower-risk devices' lighter-touch requirements slip simply because they're quieter.
This triage work is part of why the job rewards organization as much as clinical judgment. It's common for one specialist to be tracking PMCF plan review dates, evaluation report due dates, and ongoing study milestones across a dozen or more devices simultaneously, each on its own regulatory clock tied to its risk classification and its CE certificate renewal cycle.
Where These Roles Sit in an Organization
PMCF specialists are most common at medical device and IVD manufacturers of meaningful size with an established CE-marked portfolio, since the volume of ongoing PMCF obligations across multiple devices is what justifies a dedicated role rather than folding it into clinical affairs generally. Smaller manufacturers or those early in their European market presence are more likely to have this work handled by a regulatory affairs or clinical affairs generalist, with the PMCF-specific title appearing as the company and its device portfolio grow.
Within larger organizations, PMCF specialists sometimes report into clinical affairs, sometimes into regulatory affairs, and occasionally into a dedicated postmarket surveillance function — the reporting structure says less about the work itself than about how a particular company has chosen to organize its postmarket obligations. What stays consistent across those structures is the need for the specialist to work fluidly across clinical, regulatory, and quality teams rather than operating in a silo, since PMCF findings routinely trigger action in all three areas.
Common Entry Points Into This Work
People arrive at PMCF roles from a few different directions. Some come from clinical research backgrounds — former clinical research associates or clinical trial managers who move into postmarket work after gaining some regulatory or quality exposure. Others come from within regulatory affairs itself, taking on PMCF responsibilities as part of a broader clinical regulatory role before the company grows enough to split it out as its own position. A smaller number come from epidemiology or biostatistics, drawn by the data analysis side of evaluating real-world evidence and registry data for safety and performance signals.
None of these paths is clearly the "right" one, and companies hiring for PMCF roles tend to value the combination of skills over a specific pedigree — someone who can both design a methodologically sound follow-up activity and translate what it finds into clear regulatory documentation tends to be more valuable than someone strong in only one of those areas. For someone early in a regulatory or clinical career who's interested in this direction, volunteering for postmarket surveillance or clinical evaluation report work, even as a secondary responsibility, is a practical way to start building the relevant experience before a dedicated PMCF role opens up.
Conclusion
PMCF work is a good example of how MDR and IVDR changed not just what documentation looks like at the time of CE marking, but what ongoing, structured work a device company has to do for as long as the device stays on the market. For someone who likes clinical research methodology but wants to be closer to the regulatory and commercial consequences of that research than a pure academic role allows, PMCF specialist is worth knowing about as a distinct career lane inside medical device regulatory affairs.